ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway = ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway

다국어 초록 (Multilingual Abstract)

[18F]Fluorodeoxyglucose (FDG) PET/CT imaging has been widely used in the diagnosis of malignant tumors. ATPase family AAA domain-containing protein 2 (ATAD2) plays important roles in tumor growth, invasion and metastasis. However, the relationship between [18F]FDG accumulation and ATAD2 expression remains largely unknown. This study aimed to investigate the correlation between ATAD2 expression and [18F]FDG uptake in lung adenocarcinoma (LUAD), and elucidate its underlying molecular mechanisms. The results showed that ATAD2 expression was positively correlated with maximum standardized uptake value (SUV_max), total lesion glycolysis (TLG), glucose transporter type 1 (GLUT1) expression and hexokinase2 (HK2) expression in LUAD tissues. In addition, ATAD2 knockdown significantly inhibited the proliferation, tumorigenicity, migration, [18F]FDG uptake and lactate production of LUAD cells, while, ATAD2 overexpression exhibited the opposite effects. Furthermore, ATAD2 modulated the glycometabolism of LUAD via AKT-GLUT1/HK2 pathway, as assessed using LY294002 (an inhibitor of PI3K/AKT pathway). In summary, to explore the correlation between ATAD2 expression and glycometabolism is expected to bring good news for anti-energy metabolism therapy of cancers. [BMB Reports 2019; 52(7): 457-462]

참고문헌 (Reference)

1 Wu G, "miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis" 14 : 1-11, 2014

2 Jadvar H, "[18F]FDG uptake in lung, breast, and colon cancers : molecular biology correlates and disease characterization" 50 : 1820-1827, 2009

3 Yamasaki T, "Roles of conserved arginines in ATP-binding domains of AAA+ chaperone ClpB from Thermus thermophiles" 278 : 2395-2403, 2011

4 Zhuo B, "PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma" 464 : 401-406, 2015

5 Cho H, "Overexpression of glucose transporter-1(GLUT-1)predicts poor prognosis in epithelial ovarian cancer" 31 : 607-615, 2013

6 Shang P, "Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis" 36 : 4479-4485, 2015

7 Hong SY, "Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein" 28 : 377-383, 2016

8 Alvarez JV, "Oncogene pathway activation in mammary tumors dictates [18F]-FDG-PET uptake" 74 : 7583-7598, 2014

9 Zheng L, "Oncogene ATAD2promotes cell proliferation, invasion and migration in cervical cancer" 33 : 2337-2344, 2015

10 Boussouar F, "Malignant genome reprogramming by ATAD2" 1829 : 1010-1014, 2013

11 Stine ZE, "MYC, metabolism, and cancer" 5 : 1024-1039, 2015

12 Wu K, "Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K/AKT and NF-kB pathway" 509 : 925-930, 2019

13 Wang H, "Inhibition of glycolytic enzyme hexokinase II(HK2)suppresses lung tumor growth" 16 : 9-, 2016

14 Wahlstrom T, "Impact of MYC in regulation of tumor cell metabolism" 1849 : 563-569, 2015

15 Caron C, "Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers" 29 : 5171-5181, 2010

16 Nouet C, "Functional analysis of yeast bcs1 mutants highlights the role of Bcs1p-specific amino acids in the AAA domain" 388 : 252-261, 2009

17 Coudray N, "Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning" 24 : 1559-1567, 2018

18 채영찬, "Cancer stem cell metabolism: target for cancer therapy" 생화학분자생물학회 51 (51): 319-326, 2018

19 Siegel RL, "Cancer statistics, 2018" 68 : 277-300, 2018

20 Tsai JS, "Cadmium activates multiple signaling pathways that coordinately stimulate Akt activity to enhance c-Myc mRNA stability" 11 : e0147011-, 2016

21 Fan Y, "Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition" 285 : 7324-7333, 2010

22 Zhang MJ, "ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker" 18 : 1-6, 2015

23 Wan WN, "ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis" 15 : 2777-2783, 2014

24 Ciro M, "ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors" 69 : 8491-8498, 2009

25 Zou JX, "ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification" 104 : 18067-18072, 2007

26 Zhang Y, "ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma" 20 : 577-582, 2013

27 Fouret R, "A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma" 18 : 5606-5616, 2012